Comment on: "Hepatitis B reactivation in PsA patients: an SLR and meta-analysis for IL-17, IL-23 and JAK inhibitors": reply
Rheumatology (Oxford)
.
2024 Nov 27:keae646.
doi: 10.1093/rheumatology/keae646.
Online ahead of print.
Authors
Theodoros Androutsakos
1
,
Konstantinos Dimitriadis
2
,
Maria-Loukia Koutsompina
1
,
Konstantinos D Vassilakis
3
,
Avraam Pouliakis
4
,
George E Fragoulis
3
Affiliations
1
Department of Pathophysiology, National and Kapodistrian University of Athens, Athens, Greece.
2
Department of Clinical Therapeutics, 'Alexandra' hospital, National and Kapodistrian University of Athens, Athens, Greece.
3
First Department of Internal Medicine, Propaedeutic Clinic, "Laiko" Hospital, National and Kapodistrian University of Athens, Athens, Greece.
4
Second Department of Pathology, National and Kapodistrian University of Athens, Athens, Greece.
PMID:
39602794
DOI:
10.1093/rheumatology/keae646
No abstract available